DNAtrix and Valo Therapeutics Enter into Strategic Partnership to Develop Peptide-Coated Oncolytic Viruses for Treating Cancer
HOUSTON and HELSINKI, Nov. 13, 2018 /PRNewswire/ -- DNAtrix and Valo Therapeutics today announced an exclusive R&D collaboration to develop...